INSIGHTS ON DRUG DEVELOPMENT
-
Enhancing Throughput And Reproducibility In Proteomic Analysis
Streamline proteomic workflows with consistent sample preparation. Discover how simplifying LC-MS processes can eliminate bottlenecks, improve reproducibility, and accelerate drug discovery research.
-
Tools For Efficient And Reliable Gene Therapy Manufacturing
Discover scalable strategies for overcoming AAV purification challenges, from low yield and impurity removal to serotype variability, as well as how advanced tools can streamline manufacturing.
-
Cell Cycle Mapping In Tumors With Advanced Technologies
Discover how spatial profiling and advanced imaging tools are transforming drug discovery, featuring Wayne Stallaert’s lab’s work on cell cycle mapping and biomarker insights in cancer research.
-
3D Cell Culture Reveals Undetectable Drug Efficacy In Traditional Systems
Drug discovery now targets cancer stem cells (CSCs) to achieve long-term tumor eradication, which moves beyond traditional chemotherapeutics. Discover an advanced screening platform that better predicts CSC inhibitor efficacy.
-
Following The Science To Develop Best-In-Class Cancer Drugs12/11/2023
As innovative cancer therapeutics continue to enter the clinical trial pipeline, some developers are shifting their focus toward developing drugs that are safe and efficacious with minimal toxicity.
-
Is Lipinski's Rule Of Five Still Relevant In Drug Development?11/13/2024
Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.
-
Support For Your Production Challenges7/15/2024
Ensure your manufacturing operations run smoothly and efficiently by collaborating with experts to tackle production, processing, or quality control issues.
-
Optimization And Scale-Up Of A Plasmid DNA Production Process9/30/2025
Optimizing pDNA production in E. coli requires strategic media selection and scale-up planning. Explore a study that identifies ideal conditions for high-yield manufacturing.
-
Cost And Scalability Key Drivers Of Expanded Gene Therapy Access5/16/2025
Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.
DRUG DEVELOPMENT SOLUTIONS
-
Digital microscopy with automated brightfield, fluorescence, and Digital Confocal imaging
The ImageXpress® Pico Automated Cell Imaging System is more than a digital microscope, combining high-resolution imaging with powerful analysis. Whether running fluorescence imaging or brightfield assays, the automated imager features a comprehensive portfolio of preconfigured protocols for cell-based assays to shorten the learning curve, so you can start running experiments quickly.
-
Early manufacturability assessments, complete cGMP solutions, and everything in between. FUJIFILM Diosynth Biotechnologies is a leading provider of cell culture services for biologics, advancing and delivering life-changing therapies.
-
Backed by trusted data and deep scientific expertise, learn how our adaptive approach ensures seamless progression from preclinical development to commercial manufacturing.
-
A60 F Stereo Microscope
Optimize your productivity and production quality
The intuitive A60 F and A60 S stereo microscopes fulfill what you need – high sample throughput, optimum visibility of product details and components, and easy processing of subassemblies.
-
See 80% more of your sample with a 46 mm object field
-
Comfortable access your sample due to the 122 mm working distance
-
Easy handling, less refocusing and time saving with up to 13.6 mm depth of field and Leica FusionOptics technology
-
Enables large surface overview and detailed observation with a magnification range from 5x to 30x
-
-
Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.